BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu Y, Mu Y, Zhang A, Ren S, Wang W, Xie J, Zhang Y, Zhou C. Cytokine-induced killer cells/dendritic cells and cytokine-induced killer cells immunotherapy for the treatment of esophageal cancer in China: a meta-analysis. Onco Targets Ther 2017;10:1897-908. [PMID: 28408841 DOI: 10.2147/OTT.S132507] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Wang Y, Lv B, Li K, Zhang A, Liu H. Adjuvant immunotherapy of dendritic cells and cytokine-induced killer cells is safe and enhances chemotherapy efficacy for multiple myeloma in China: a meta-analysis of clinical trials. Drug Des Devel Ther 2017;11:3245-56. [PMID: 29180849 DOI: 10.2147/DDDT.S146959] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
2 Zhang Y, Zhang X, Zhang A, Li K, Qu K. Clinical applications of dendritic cells-cytokine-induced killer cells mediated immunotherapy for pancreatic cancer: an up-to-date meta-analysis. Onco Targets Ther 2017;10:4173-92. [PMID: 28860827 DOI: 10.2147/OTT.S143382] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
3 Ni L. Advances in Human Dendritic Cell-Based Immunotherapy Against Gastrointestinal Cancer. Front Immunol 2022;13:887189. [PMID: 35619702 DOI: 10.3389/fimmu.2022.887189] [Reference Citation Analysis]
4 Pei Y, Zhu Y, Wang X, Xu L. The expression and clinical value of tumor infiltrating dendritic cells in tumor tissues of patients with esophageal cancer. J Gastrointest Oncol 2021;12:1996-2003. [PMID: 34790367 DOI: 10.21037/jgo-21-578] [Reference Citation Analysis]